Discussing the opportunity for generic drug makers to make big profits, with Heather Bresch, Mylan president.
Teva announces it beat out Pfizer in a $5B deal for a privately held generic drug-maker in Germany, with William Marth, Teva Pharmaceutical North America CEO and CNBC's Mike Huckman.
Satish Reddy, Dr. Reddy's Labs COO, discusses the generic drug business with CNBC's Mike Huckman.
Almost $150 billion worth of brand-name prescription drugs will lose their patents over the next five years. Kathleen Jaegar, president and CEO of the Generic Pharmaceutical Association, tells CNBC's Mike Huckman what this will mean for generic drug co...
May 26: According to the Congressional Budget Office, generic drugs save consumers at least $8 billion every year, but are they always the best choice? NBC’s chief medical editor Dr. Nancy Snyderman reports on the risks and benefits associated with generics.
GLENSIDE, PA - SEPTEMBER 7: Pharmacist Howard Brooker fills a prescription at Adams Discount Pharmacy September 7, 2006 in Glenside, Pennsylvania. Adams offers generic drugs for forty to seventy five percent cheaper than the brand name manufacturer's cost. They are able to charge low prices by not